Loading company…
Ottawa-based Spiderwort develops plant-based cellulose biomaterials for spinal cord repair and aesthetic dermal fillers.
Founded in 2015 in Ottawa, Canada, Spiderwort Inc. develops plant-based biomaterials for regenerative medicine, particularly neurology and aesthetic uses. Its products are CelluBridge®, a scaffold for spinal cord tissue repair, and CelluJuve®, a dermal filler, both aimed at healthcare facilities, clinics and aesthetic practices. The company raised USD 13.2 mn in Series A funding led by Horizons Ventures on July 12, 2022, and Charles Cuerrier is CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in